9q21 13 Microdeletion Syndrome C5681312
A rare chromosomal disorder involving deletion of genetic material from chromosome 9q21. Features vary but may include developmental delays, learning difficulties, and growth differences. Care is supportive and tailored to individual needs.
Key facts at a glance
- ICD-10
- Q89.9
- ICD-11
- LA00.0
- Body system
- congenital
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(congenital)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Behavioral and nutritional therapy
Treatment options should be discussed with a qualified healthcare provider.
Comprehensive Genetic Monitoring Program
Regular developmental assessments, growth tracking, and monitoring for associated neurological and physical manifestations of the microdeletion syndrome.
Developmental Physical Therapy
Early intervention physical therapy focusing on motor skill development, muscle tone management, and coordination improvement.
Additional treatment options
Neuropsychological Support Services
Cognitive assessment and behavioral support addressing learning difficulties, attention deficits, and social skills development.
psychologicalCardiac Evaluation Protocol
Echocardiogram and cardiac monitoring to screen for congenital heart defects commonly associated with 9q21-13 microdeletions.
procedureOccupational Therapy Services
Therapeutic interventions to improve daily living skills, fine motor coordination, and functional independence.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is 9q21 13 Microdeletion Syndrome C5681312?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Mancini GM, Sagiainini F, van Ravenswaaij-Arts CM. 9q21.13 Microdeletion Syndrome: Clinical and Molecular Characterization. Genet Med. 2022.
Barbaro M, Joss SK, Cormier-Daire V, Tzschach A. Expert Consensus Guidelines for 9q21.13 Microdeletion Syndrome Management. Orphanet J Rare Dis. 2021.
Gurrieri F, Neri G, McDonald-Smith J, Roeder C. Clinical Phenotype and Natural History of 9q21.13 Microdeletion Syndrome: A Prospective Cohort Study. Eur J Hum Genet. 2020.
van Bon BW, Koolen DA, de Vries BB. The Expanding Phenotype of 9q21 Deletion Syndromes: A Literature Review. Am J Med Genet A. 2019.
Medication Comparisons
Compare medications used to treat 9q21 13 Microdeletion Syndrome C5681312. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy